Cyprotex at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Cyprotex takes part in 2 sessions at ACT 2026 in San Antonio, and exhibits at Booth 209. Its program centres on pairing gene expression data and AI with human-relevant lab models to spot liver, heart and kidney toxicity early.

OrganizationACT 2026 Attendance
Cyprotex
Cheshire, UK
Specialist testing laboratories
Evotec company providing in vitro ADME-PK and predictive toxicology assays plus in silico models, with labs in Massachusetts and the UK.
Booth
Exhibiting at Booth 209
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm
Poster
Mon Nov 16
5:00pm–6:30pm
Mechanistic, Multi‑Organ Toxicity Assessment Using AI‑Driven Transcriptomics in Human‑Relevant In Vitro Models (P426)
Nelson Exhibit Ballroom · Poster P426
New approach methods · In silico and AI
Talk
Wed Nov 18
12:00pm–12:55pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Cyprotex

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction